Radiology

Sirtex Medical Launches SIR-Spheres® FLEXdose SELECT Delivery Program to Enable More Selective Y-90 Treatment Plans

WOBURN, Mass., Aug. 5, 2024 /PRNewswire/ — Sirtex Medical (“Sirtex”), a leading manufacturer of interventional treatment solutions, announced today the launch of its SIR-Spheres® FLEXdose SELECT Delivery Program, an innovative, new way to offer precise Y-90 selective internal radiation therapy for the treatment of metastatic colorectal cancer.   SIR-Spheres® FLEXdose SELECT Delivery Program offers unparalleled flexibility by […]

Attralus Receives Breakthrough Therapy Designation for its Pan-Amyloid Diagnostic PET Imaging Candidate 124I-evuzamitide (AT-01) for Cardiac Amyloidosis

BURLINGAME, Calif., Aug. 05, 2024 (GLOBE NEWSWIRE) — Attralus, Inc., a clinical stage biopharmaceutical company developing transformative products to improve the lives of patients with systemic amyloidosis, today announced that its investigational diagnostic imaging agent drug, 124I-evuzamitide (AT-01), has been granted Breakthrough Therapy Designation (BTD) by the U.S. Food and Drug Administration (FDA) for positron emission tomography (PET) imaging in patients with suspected or known cardiac amyloidosis. FDA granted BTD for 124I-evuzamitide (AT-01) based on clinical data from Attralus-sponsored and investigator-initiated studies evaluating the use of 124I-evuzamitide in patients with cardiac amyloidosis, representing experience in more than 200 trial participants.

Access Vascular Prepares Catheter Location Technology for FDA Submission

BILLERICA, Mass.–(BUSINESS WIRE)–Access Vascular, Inc. (AVI), a medical device company dedicated to reducing and eliminating common and costly vascular access complications with its novel MIMIX® catheter material, announced today that it is preparing to submit its HydroGUIDE™ catheter placement technology for U.S. Food & Drug Administration (FDA) clearance. “Combining the innovative […]

GE HealthCare announces agreement to acquire clinical artificial intelligence business from Intelligent Ultrasound

Agreement to acquire business adds innovative, real-time image recognition technology and expertise to GE HealthCare’s portfolio of AI-enabled devices AI-based technology from Intelligent Ultrasound aims to provide real-time support for OBGYN scans and improve exam accuracy and efficiency Planned acquisition supports GE HealthCare’s precision care strategy to address inefficiencies and […]

At AHRA 2024, Agfa Radiology Solutions highlights intelligent technologies and systems that ensure “One image is all it takes”

MORTSEL, Belgium, July 17, 2024 /PRNewswire/ — At the Annual Meeting of AHRA (the Association for Medical Imaging Management), Agfa Radiology Solutions will demonstrate how its solutions help customers address staffing shortages and tight budgets.

Continue Reading

Agfa’s comprehensive portfolio supports “The Next Generation” in medical imaging by using intelligent and innovative technologies to ensure every X-ray image counts. With accurate and high-quality diagnostic information from the first image taken, retakes are reduced: speeding up workflows and enhancing the experience of radiologist, radiographer and patient.

Agfa Radiology Solutions uses intelligent and innovative technologies to ensure every X-ray image in healthcare counts.

Post this

“We understand the challenges our customers are facing in terms of staffing shortages and decreased budgets. Our productivity features and ‘one image is all it takes’ approach empower each X-ray expert to work more efficiently. Additionally, the DR 100 Essential and VALORY™ are designed to be budget-friendly, but still deliver all the essential functions healthcare facilities need – including our renowned MUSICA® image processing software. They demonstrate our commitment to offering solutions that ensure healthcare facilities never need to compromise on image quality, regardless of their staff and budget constraints,” says Bruce Romaglia, Vice President – North America at Agfa Radiology Solutions.
At Agfa’s booth, visitors can discover solutions and special packages that help bring those advantages to every healthcare organization, whatever their budgets.Intelligent technologies for image processing and workflow assistance:
MUSICA®, which comes standard with all Agfa DR and CR systems, automatically analyses the characteristics of raw images and optimizes the processing parameters, independent of body part or dose deviation. Its high image quality and low-dose features have made MUSICA® the “gold standard” in image processing for radiology departments around the world.
The SmartXR® portfolio adds X-ray intelligence to Agfa’s DR solutions, to provide image acquisition support and lighten the radiographer’s workload. Predictive workflow assistance for dose, alignment, patient positioning, image rotation and more help improve operational performance in image acquisition.
About AgfaAgfa develops, produces and distributes an extensive range of imaging systems and workflow solutions for the printing industry, the healthcare sector, as well as for specific hi-tech industries such as printed electronics & renewable energy solutions.The headquarters are located in Belgium. The largest production and research centers are located in Belgium, the United States, Canada, Germany, France, the United Kingdom, Austria, China and Brazil. Agfa is commercially active worldwide through wholly owned sales organizations in more than 40 countries.For more information on Agfa please visit www.agfa.comFollow us at TwitterAgfa, the Agfa rhombus, MUSICA and SmartXR are trademarks of Agfa-Gevaert N.V. Belgium or its affiliates. All rights reserved.All information contained herein is intended for guidance purposes only, and characteristics of the products and services described in this publication can be changed at any time without notice. Products and services may not be available for your local area. Please contact your local sales representative for availability information. Agfa diligently strives to provide as accurate information as possible, but shall not be responsible for any typographical error.Only the English version of this press release is legally valid. The versions in other languages only represent a translation of the original English version.SOURCE AGFA US Corp.

Phoenix Cardiology Practice Installs the First and Fastest Cardiovascular CT Scanner in the State, Arineta’s SpotLight Duo

Caesarea, Israel – July 9, 2024 – Arineta, a leader in advancing cardiovascular imaging solutions through cutting-edge technology, proudly announces the latest installation of its SpotLight™ Duo at Cardiovascular Consultants, Ltd. (CVC) in Arizona. This makes CVC the first and only practice in the southwest region to have the world’s […]

Centerline Biomedical joins ORSIF

Centerline Biomedical and ORSIF join together to raise awareness of health risks associated with fluoroscopic radiation and solutions available to medical professionals. 
CLEVELAND, July 9, 2024 /PRNewswire/ —  Centerline Biomedical, Inc. (“Centerline”), joins ORSIF, the organization for Occupational Radiation Safety in International Fluoroscopy, to raise awareness of technology options to improve safety in the work environment where fluoroscopic x-ray radiation is used in medical procedures. As a corporate partner, Centerline supports ORSIF (www.orsif.org) in a shared mission to champion innovation for safer healthcare. In addition, the developing platform aims to continue bringing together healthcare providers and their organizations, professional medical societies, and industry to provide education on radiation safety.
“We are proud to join ORSIF in its mission to create greater awareness in the medical community regarding the dangers of radiation exposure and to protect those who commit their lives to the wellness of others. To that end, IOPS® (Intra-Operative Positioning System) technology enables improved visualization with 3D navigation in endovascular procedures while minimizing the reliance on damaging radiation,” said Gulam Khan, CEO of Centerline Biomedical.  “Employees at Centerline are inspired every day to design the future of image guidance technology that enables faster, more precise transcatheter procedures while reducing the use of radiation.”  
Designed to mitigate radiation exposure during minimally invasive cardiovascular procedures, Centerline Biomedical IOPS (Intra-Operative Positioning System) is a novel technology gaining increased application in the US. IOPS includes software that creates 3D maps of vascular anatomy, enabling surgeons to visualize the arteries being treated. Using electromagnetic tracking, IOPS sensor-equipped guidewires and catheters can be guided in 3D as endovascular specialists navigate through these high-resolution intuitive visualizations during minimally invasive procedures. The images and tracking are displayed on an independent monitor, minimizing the reliance on damaging X-ray radiation typically used to produce live fluoroscopic images during interventions. 
About Centerline BiomedicalFounded in 2015, Centerline Biomedical is headquartered in Cleveland, Ohio. The company’s commercially available platform, IOPS®, Intra-Operative Positioning System, enables improved visualization and navigation in endovascular procedures. IOPS has 510(k) clearance from the US FDA for use in the descending aorta. The company continues investment in development to enhance the current technology platform and expand image guidance in transcatheter procedure applications.
Visit www.centerlinebiomedical.com for more information.
SOURCE Centerline Biomedical